3
Shared Docs
3
Same-Page
3 / 3
Mentions
mpanies by lying about Bitcoin transactions. Jon Barry Thompson, also known as J. Barry Thompson, was th
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
g about Bitcoin transactions. EFTA00069914 Jon Barry Thompson, also known as J. Barry Thompson, was th
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
mpanies by lying about Bitcoin transactions. Jon Barry Thompson, also known as J. Barry Thompson, was th
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
Entities connected to both Barry Diller and Investigational New Drug (IND

Jeffrey Epstein
PERSON
Prince Andrew
PERSON
Alan Dershowitz
PERSON
Donald Trump
PERSON
Marc Rich
PERSON
United States
LOCATION
Department of Justice
ORGANIZATION
Stephen Hawking
PERSON
Alexander Acosta
PERSON
Julie K. Brown
PERSON
Eric Trump
PERSON
Bill Clinton
PERSON
Ghislaine Maxwell
PERSON
Bradley Edwards
PERSONMartin Weinberg
PERSON
New York
LOCATION
Virginia Giuffre
PERSON
Kenneth Marra
PERSON
Jared Kushner
PERSON
Lawrence Krauss
PERSON